Download FREE Report Sample
Download Free sampleAmiodarone?is an antiarrhythmic medication that affects the rhythm of heartbeats.Amiodarone is used to help keep the heart beating normally in people with life-threatening heart rhythm disorders of the ventricles (the lower chambers of the heart that allow blood to flow out of the heart). Amiodarone is used to treat or prevent ventricular tachycardia or ventricular fibrillation.
Amiodarone Injection Market contains market size and forecasts of Amiodarone Injection in global, including the following market information:
Global Amiodarone Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Amiodarone Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Amiodarone Injection companies in 2021 (%)
The global Amiodarone Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
15mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amiodarone Injection include Baxter, AuroMedics, Fresenius Kabi, Hikma, Mylan, Sagent, Bioniche Pharma, Sanofi and Prism Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amiodarone Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amiodarone Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amiodarone Injection Market Segment Percentages, by Type, 2021 (%)
15mg/ml
50mg/ml
Global Amiodarone Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amiodarone Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Recovery Center
Global Amiodarone Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amiodarone Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Amiodarone Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Amiodarone Injection revenues share in global market, 2021 (%)
Key companies Amiodarone Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Amiodarone Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
AuroMedics
Fresenius Kabi
Hikma
Mylan
Sagent
Bioniche Pharma
Sanofi
Prism Pharmaceutical
Fangming Pharmaceutical Group
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy